BridgeBio · 1 week ago
Associate Director, Biostatistics
United States
Full-time
Remote
Senior Level, Lead/Staff, Director/Executive
$195K/yr - $230K/yr
7+ years expBridgeBio is a biopharmaceutical company focused on developing medicines for patients with unmet needs. The Associate Director, Biostatistics will oversee statistical activities supporting Medical Affairs, contributing to medical strategy and communications, while managing CRO interactions and ensuring high-quality statistical deliverables.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Provide statistical input to medical publications, scientific congresses, and external collaborations
Apply appropriate statistical methodologies supporting medical insights, value demonstration, safety monitoring, and lifecycle management
Ensure high-quality statistical deliverables that meet scientific and regulatory standards
Partner with colleagues in Medical Affairs, HEOR, Clinical Development, and other cross-functional teams to align statistical activities
Translate statistical concepts into clear insights for medical and scientific stakeholders
Stay current with evolving statistical methods, data sources, and regulatory expectations related to real-world evidence
CRO / Vendor Oversight: Establishes procedures through regular interaction, setting expectations on deliverables and timelines to guide the CRO biostatistician and statistical programmers. Ensures deliverables are accurate and delivered according to the timelines
Qualification
Required
PhD or Master's degree in Biostatistics, Statistics, or related field
7+ years (PhD) or 10+ years (Master's) of biostatistics experience in the pharmaceutical/biotech industry
Strong knowledge of statistical methodologies, current drug development trends, and regulatory environments
Strong analytical and problem-solving skills; able to identify and investigate issues and causes independently and formulate potential solutions
Excellent written and verbal communication skills, with the ability to engage both technical and non-technical audiences
Excellent programming skills in SAS and/or R
Ability to work as a part of a cross-functional team in a fast-paced environment and to work collaboratively with external partners and vendors
Preferred
Experience contributing to medical publications and scientific communications
Familiarity with HEOR and real-world evidence analysis
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
201-500 employees
H1B Sponsorship
BridgeBio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (5)
2023 (4)
2022 (4)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$4.35BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
2024-01-18Post Ipo Debt· $1.25B
Leadership Team
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
Neil Kumar
CEO and Founder
Recent News
2026-01-05
2025-12-24
2025-12-11
Company data provided by crunchbase